Answers are grounded in this paper and cite their sources.
Original synthesis reveals strategies for producing complex sialylated glycans, indicating potential for neurobiological applications.
Gangliosides are a diverse class of glycosphingolipids whose sialylated glycans regulate processes ranging from neuronal repair to immune responses. Among them, SJG-2, an echinoderm-derived ganglioside with potent neuroregenerative activity, stands out for its rare and highly branched trisialylated glycan motif. The unusual architecture of the heptasaccharide SJG-2 glycan with two terminal sialic acids attached to galactose (Gal) via α(2,3)- and α(2,4)-sialylations and an additional internal β(1,8)-sialylation to another sialic acid has rendered it synthetically inaccessible for over two decades. Here, we report the first total synthesis of the SJG-2 glycan. A conformational inversion strategy using a ¹C₄-configured Gal acceptor enabled efficient α(2,4)- and α(2,3)-sialylations. In the key convergent [4 + 3] glycosylation, selective N-acetyl,5-N,4-O-carbonyl protection of sialic acid suppressed competing C8 reactivity, while subsequent deacetylation proved essential for forming the β(1,8)-glycosidic bond. This work achieves a long-standing synthetic goal and establishes broadly applicable strategies for constructing sterically congested sialylated glycans, opening new opportunities to access complex gangliosides and explore their neurobiological functions.
No takes yet. Share an insight, caveat, or question.
Su et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: